Apr 24 |
CureVac N.V. (CVAC) Q4 2023 Earnings Call Transcript
|
Apr 24 |
CureVac N.V. 2023 Q4 - Results - Earnings Call Presentation
|
Apr 24 |
CureVac reports Q4 results
|
Apr 24 |
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
|
Apr 24 |
CureVac Appoints Thaminda Ramanayake as New Chief Business Officer
|
Apr 24 |
CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK
|
Apr 24 |
CureVac to cut costs in restructuring
|
Apr 23 |
CureVac BV FQ4 2023 Earnings Preview
|
Apr 23 |
CureVac N.V. (NASDAQ:CVAC) stock most popular amongst private equity firms who own 31%, while individual investors hold 30%
|
Apr 18 |
CureVac to Report Fourth Quarter and Full-Year 2023 Financial Results and Business Update on April 24, 2024
|